Chemomab Therapeutics, Scipher Medicine announce merger agreement
Chemomab Therapeutics and Scipher Medicine announced that they have entered into a definitive merger agreement pursuant to which the companies will combine in a stock transaction. Upon completion of the merger, the combined company expects to operate as Scipher Medicine and trade on Nasdaq under the ticker symbol (SCIP